NOAC-话题@MedSci - 梅斯（MedSci）

#NOAC#

28篇内容 | 1683人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1507562, encodeId=f252150e562db, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=NOACs对常规凝血试验的影响—案例分享ABC, objectType=article, longId=729038, objectId=2a76e29038b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a76e29038b7, replyNumber=0, likeNumber=125, createdTime=2022-06-11, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a76e29038b7, moduleTitle=NOACs对常规凝血试验的影响—案例分享ABC, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2a76e29038b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507560, encodeId=a805150e5607d, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=Stroke：虚弱的房颤患者，抗凝治疗更有效，且NOAC可降低卒中、出血发生率和死亡率, objectType=article, longId=299911, objectId=15b6299911a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15b6299911a2, replyNumber=0, likeNumber=124, createdTime=2022-03-03, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15b6299911a2, moduleTitle=Stroke：虚弱的房颤患者，抗凝治疗更有效，且NOAC可降低卒中、出血发生率和死亡率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=15b6299911a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507561, encodeId=bffa150e561c6, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JAMA：意外！近期使用NOACs与rt-PA治疗的急性缺血性中风患者的颅内出血无关！, objectType=article, longId=299585, objectId=0678299585a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0678299585a3, replyNumber=0, likeNumber=104, createdTime=2022-02-26, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0678299585a3, moduleTitle=JAMA：意外！近期使用NOACs与rt-PA治疗的急性缺血性中风患者的颅内出血无关！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0678299585a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507559, encodeId=2f7b150e559b5, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JAHA：房颤和主动脉瓣狭窄患者接受NOAC与华法林治疗的疗效和安全性分析, objectType=article, longId=221073, objectId=0cb32210e36d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cb32210e36d, replyNumber=0, likeNumber=81, createdTime=2021-11-27, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cb32210e36d, moduleTitle=JAHA：房颤和主动脉瓣狭窄患者接受NOAC与华法林治疗的疗效和安全性分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0cb32210e36d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507558, encodeId=5566150e558d4, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！, objectType=article, longId=210559, objectId=4e612105596b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e612105596b, replyNumber=0, likeNumber=79, createdTime=2021-04-29, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e612105596b, moduleTitle=EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4e612105596b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507557, encodeId=72c8150e5578b, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=聚焦房颤导管消融围手术期，解析NOAC抗凝治疗价值, objectType=article, longId=203975, objectId=282e2039e503, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=282e2039e503, replyNumber=0, likeNumber=82, createdTime=2020-12-02, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=282e2039e503, moduleTitle=聚焦房颤导管消融围手术期，解析NOAC抗凝治疗价值, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=282e2039e503)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507556, encodeId=3f9c150e556cd, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=ESC 2020访谈：马长生：ABC途径让房颤管理更简洁，NOAC广泛应用将推动抗凝治疗率提升, objectType=article, longId=200808, objectId=8a82200808c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a82200808c5, replyNumber=0, likeNumber=85, createdTime=2020-09-19, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a82200808c5, moduleTitle=ESC 2020访谈：马长生：ABC途径让房颤管理更简洁，NOAC广泛应用将推动抗凝治疗率提升, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8a82200808c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507555, encodeId=0b70150e555fa, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=Stroke: 心房颤动及ICH病史人群，使用NOAC可能更安全, objectType=article, longId=188208, objectId=51ee188208fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51ee188208fd, replyNumber=0, likeNumber=83, createdTime=2020-02-17, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51ee188208fd, moduleTitle=Stroke: 心房颤动及ICH病史人群，使用NOAC可能更安全, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=51ee188208fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507554, encodeId=7898150e55427, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JAHA：NOACs与华法林对房颤患者痴呆发生的影响, objectType=article, longId=167447, objectId=716016e44769, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=716016e44769, replyNumber=0, likeNumber=75, createdTime=2019-06-03, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=716016e44769, moduleTitle=JAHA：NOACs与华法林对房颤患者痴呆发生的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=716016e44769)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507553, encodeId=d20b150e55360, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JACC：NOAC增加NVAF患者重度肝损伤风险？, objectType=article, longId=134602, objectId=aa8d134602c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa8d134602c2, replyNumber=0, likeNumber=114, createdTime=2018-04-10, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa8d134602c2, moduleTitle=JACC：NOAC增加NVAF患者重度肝损伤风险？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aa8d134602c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507552, encodeId=1ed8150e552c3, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, objectType=article, longId=134289, objectId=c5a613428989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5a613428989, replyNumber=0, likeNumber=66, createdTime=2018-04-06, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5a613428989, moduleTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c5a613428989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507551, encodeId=7cf7150e55105, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JACC：NOACs并不会增加房颤患者肝脏损伤的风险, objectType=article, longId=131938, objectId=df6a13193864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df6a13193864, replyNumber=0, likeNumber=99, createdTime=2018-03-11, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df6a13193864, moduleTitle=JACC：NOACs并不会增加房颤患者肝脏损伤的风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=df6a13193864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507550, encodeId=3dea150e55057, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JAMA：颅内出血患者服用NOACs及华法林的死亡风险, objectType=article, longId=128727, objectId=733d128e27de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=733d128e27de, replyNumber=0, likeNumber=77, createdTime=2018-02-04, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=733d128e27de, moduleTitle=JAMA：颅内出血患者服用NOACs及华法林的死亡风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=733d128e27de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507549, encodeId=d4ab150e54953, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=J Intern Med：使用标准剂量和低剂量NOAC的AF患者卒中风险无差异？, objectType=article, longId=128539, objectId=09e4128539e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09e4128539e7, replyNumber=0, likeNumber=71, createdTime=2018-02-03, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09e4128539e7, moduleTitle=J Intern Med：使用标准剂量和低剂量NOAC的AF患者卒中风险无差异？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=09e4128539e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507548, encodeId=0421150e548ad, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JACC：NOACs相比华法林对房颤患者肾脏影响更小, objectType=article, longId=121090, objectId=d710121090ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d710121090ce, replyNumber=0, likeNumber=143, createdTime=2017-11-24, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d710121090ce, moduleTitle=JACC：NOACs相比华法林对房颤患者肾脏影响更小, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d710121090ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507547, encodeId=f0de150e54717, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JAMA：华法林有合并用药的安全性问题，NOAC也一样, objectType=article, longId=119068, objectId=18a01190683a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18a01190683a, replyNumber=0, likeNumber=97, createdTime=2017-11-08, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18a01190683a, moduleTitle=JAMA：华法林有合并用药的安全性问题，NOAC也一样, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=18a01190683a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507546, encodeId=becf150e546e5, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, objectType=article, longId=118856, objectId=23071188567a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23071188567a, replyNumber=0, likeNumber=130, createdTime=2017-11-07, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23071188567a, moduleTitle=Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=23071188567a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507545, encodeId=eadb150e5450a, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=Int J Cardiol：使用PSS进行PVI后：NOAC与苯丙香豆素抗凝哪个更安全？, objectType=article, longId=118428, objectId=e1b8118428ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1b8118428ae, replyNumber=0, likeNumber=84, createdTime=2017-11-03, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1b8118428ae, moduleTitle=Int J Cardiol：使用PSS进行PVI后：NOAC与苯丙香豆素抗凝哪个更安全？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e1b8118428ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507544, encodeId=87e1150e5443a, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=JAHA：瓣膜性心脏病合并AF：NOAC vs华法林, objectType=article, longId=112900, objectId=0d15112900c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d15112900c2, replyNumber=0, likeNumber=83, createdTime=2017-09-16, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d15112900c2, moduleTitle=JAHA：瓣膜性心脏病合并AF：NOAC vs华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0d15112900c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1507543, encodeId=8ae1150e5436e, content=<a href='/topic/show?id=528b12904c3' target=_blank style='color:#2F92EE;'>#NOAC#</a>, objectTitle=Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林, objectType=article, longId=108547, objectId=c68710854ef0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68710854ef0, replyNumber=0, likeNumber=81, createdTime=2017-08-13, rootId=0, userName=30397607, userId=418f9911898, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68710854ef0, moduleTitle=Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c68710854ef0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NOAC

2020-05-29

30397607 (审核中...)

前往app查看评论内容

#NOAC#

NOACs对常规凝血试验的影响—案例分享ABC

2022-06-11

30397607 (审核中...)

前往app查看评论内容

#NOAC#

Stroke：虚弱的房颤患者，抗凝治疗更有效，且NOAC可降低卒中、出血发生率和死亡率

2022-03-03

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JAMA：意外！近期使用NOACs与rt-PA治疗的急性缺血性中风患者的颅内出血无关！

2022-02-26

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JAHA：房颤和主动脉瓣狭窄患者接受NOAC与华法林治疗的疗效和安全性分析

2021-11-27

30397607 (审核中...)

前往app查看评论内容

#NOAC#

EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！

2021-04-29

30397607 (审核中...)

前往app查看评论内容

#NOAC#

聚焦房颤导管消融围手术期，解析NOAC抗凝治疗价值

2020-12-02

30397607 (审核中...)

前往app查看评论内容

#NOAC#

ESC 2020访谈：马长生：ABC途径让房颤管理更简洁，NOAC广泛应用将推动抗凝治疗率提升

2020-09-19

30397607 (审核中...)

前往app查看评论内容

#NOAC#

Stroke: 心房颤动及ICH病史人群，使用NOAC可能更安全

2020-02-17

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JAHA：NOACs与华法林对房颤患者痴呆发生的影响

2019-06-03

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JACC：NOAC增加NVAF患者重度肝损伤风险？

2018-04-10

30397607 (审核中...)

前往app查看评论内容

#NOAC#

Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？

2018-04-06

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JACC：NOACs并不会增加房颤患者肝脏损伤的风险

2018-03-11

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JAMA：颅内出血患者服用NOACs及华法林的死亡风险

2018-02-04

30397607 (审核中...)

前往app查看评论内容

#NOAC#

J Intern Med：使用标准剂量和低剂量NOAC的AF患者卒中风险无差异？

2018-02-03

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JACC：NOACs相比华法林对房颤患者肾脏影响更小

2017-11-24

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JAMA：华法林有合并用药的安全性问题，NOAC也一样

2017-11-08

30397607 (审核中...)

前往app查看评论内容

#NOAC#

Circulation：非瓣膜性房颤合并阿司匹林治疗的患者使用NOACs的疗效和安全性分析！

2017-11-07

30397607 (审核中...)

前往app查看评论内容

#NOAC#

Int J Cardiol：使用PSS进行PVI后：NOAC与苯丙香豆素抗凝哪个更安全？

2017-11-03

30397607 (审核中...)

前往app查看评论内容

#NOAC#

JAHA：瓣膜性心脏病合并AF：NOAC vs华法林

2017-09-16

30397607 (审核中...)

前往app查看评论内容

#NOAC#

Stroke：既往卒中或TIA的非瓣膜性房颤患者：3种NOACs vs华法林

2017-08-13

科室
- - 订阅+
  - 更多科室
工具
服务